Personality disorders
56 results
1 - 56
USPSTF 2023: Screen pregnant persons for hypertensive disorders throughout pregnancy (B recommendation)- USPSTF 2023: Screening recommended for anxiety in adults, including in pregnant and postpartum persons (B recommendation)
- Safety of buprenorphine for opioid use disorder in pregnancy
- Neuropsychiatric disorders associated with glucocorticoids
- The terms "addiction" or "substance use" preferred by patients receiving methadone
- Cannabis use is common among patients with rheumatologic illness
- Stress-related disorder increases risk of subsequent autoimmune disease
- USPSTF 2022: Screening for anxiety is recommended in children and adolescents aged 8 to 18 years (B recommendation)
- ADHD drugs do not increase serious CV events in children and young adults
- IVF associated with small risk of mental retardation but not autism
- Delivery of bad news via phone = in-person delivery
- Little evidence of causal relationship between assisted reproductive technologies and neurodevelopmental disorders in childhood
- Nondrug therapy provides modest short-term improvement in fatigue in older adults
- Psychiatric problems do not increase after induced abortion
- Minimal, if any, association between labor epidural analgesia and the risk of autism spectrum disorder in children
- USPSTF 2020 recommends screening for unhealthy drug use in adults by asking questions (B recommendation)
- USPSTF 2020: insufficient evidence to recommend counseling to prevent illicit drug use in kids and young adults (I statement)
- Italian guideline on diagnosing and managing dementia and mild cognitive impairment in adults
- Psychological interventions reduce onset of depression
- Antenatal corticosteroid exposure associated with mental and behavioral disorders
- Comprehensive intervention in childhood reduces adult psychopathology
- Benefits and harms of atypical antipsychotics for off-label use
- Guidelines for decreasing the risk of suicide
- USPSTF 2017 does not recommend for or against screening for celiac disease in asymptomatic patients (I statement)
- Genetic test results that identify increased risk do not change behavior
- Buprenorphine combined with naloxone is safe and effective for opioid use disorder in pregnancy
- Autism not linked to thimerosol in vaccines
- Most children born prematurely survive to early- to mid-adulthood without major comorbidities
- Moderate or better evidence for specific cannabinoids for chronic pain, Tourette, epilepsy, spasticity, sleep, Parkinson, and other conditions
- USPSTF 2024: Insufficient evidence to screen or supplement for iron deficiency in pregnancy (I statement)
- Increased health risk in long-term survivors of childhood cancer
- Mirtazapine does not reduce agitated behaviors in persons with dementia (SYMBAD)
- Arthroscopy better than personalized physical therapy in young people with femoroacetabular impingement syndrome
- Acupuncture improves sleep quality in cancer survivors with sleep disorders and chronic pain (PEACE)
- Problem-solving therapy effective for depression with executive dysfunction
- Baloxavir similar to oseltamivir to reduce symptoms; no benefit after 36 hours or if older than 65 years (CAPSTONE-2)
- British Society of Gastroenterology guidelines for the evaluation and management of dyspepsia
- Generic anticonvulsants assoc with worse outcomes, higher expense than brand
- American College of Gastroenterology guideline on managing irritable bowel syndrome
- Concomitant use of oral anticoagulants and SSRIs associated with increased risk of major bleeding
- DMPA associated with reduced risk for ovarian cancer
- Intensive therapy = standard weekly cognitive therapy for PTSD
- AAN guideline on managing painful diabetic polyneuropathy